Exact Mass: 685.3111
Exact Mass Matches: 685.3111
Found 83 metabolites which its exact mass value is equals to given mass value 685.3111,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Viomycin
Tuberactinomycin B; Vinacetin A; Vioactane
A cyclic peptide antibiotic produced by the actinomycete Streptomyces puniceus, used in the treatment of tuberculosis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Avadharidine
Aconitane-7,8-diol, 4-(((2-((4-amino-1,4-dioxobutyl)amino)benzoyl)oxy)methyl)-20-ethyl-1,6,14,16-tetramethoxy-, (1alpha,6beta,14alpha,16beta)-
3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin
3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin
1-(N-methyl-L-phenylalanyl)-L-proline (4S)-7t-benzyl-5,8-dioxo-3t-phenyl-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Feretin|Feretine|N-demethyl-adouetine-Z
1-(N-methyl-L-phenylalanyl)-L-proline (4S)-7t-benzyl-5,8-dioxo-3t-phenyl-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Feretin|Feretine|N-demethyl-adouetine-Z
2,14-Diacetoxy-1-furoyloxydihydro-6-(2-methylbutanoyloxy)-9-nicotinoyloxy-beta-agarofuran
2,14-Diacetoxy-1-furoyloxydihydro-6-(2-methylbutanoyloxy)-9-nicotinoyloxy-beta-agarofuran
1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-furoyloxy-11-(2-methyl)butyryloxy-4beta-hydroxydihydro-beta-agarofuran|2,6-Diacetoxy-9-furoyloxydihydro-14-(2-methylbutanoyloxy)-1-nicotinoyloxy-beta-agarofuran
1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-furoyloxy-11-(2-methyl)butyryloxy-4beta-hydroxydihydro-beta-agarofuran|2,6-Diacetoxy-9-furoyloxydihydro-14-(2-methylbutanoyloxy)-1-nicotinoyloxy-beta-agarofuran
3beta-O-propionyl-5alpha,10beta,14beta-tri-O-acetyl-8beta-O-nicotinoylcyclomyrsinol|euphorbialoid G
3beta-O-propionyl-5alpha,10beta,14beta-tri-O-acetyl-8beta-O-nicotinoylcyclomyrsinol|euphorbialoid G
15beta-hydroxy-3beta-isobutanoyloxy-8alpha-nicotinyloxy-5alpha,7beta,9alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane M
15beta-hydroxy-3beta-isobutanoyloxy-8alpha-nicotinyloxy-5alpha,7beta,9alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane M
15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinyloxy-3beta,5alpha,8alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane N
15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinyloxy-3beta,5alpha,8alpha-triacetyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane N
2-Chloro-4-[2-(2,4-di-tert-pentylphenoxy)butyryl amino]-4,4-dimethyl-2-(5,5-dimethyl-2,4-dioxo-3-oxazolidinyl)-3-oxapentananilide
2-Chloro-4-[2-(2,4-di-tert-pentylphenoxy)butyryl amino]-4,4-dimethyl-2-(5,5-dimethyl-2,4-dioxo-3-oxazolidinyl)-3-oxapentananilide
Enviomycin
3,6-diamino-N-[(6Z)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C258 - Antibiotic
5-({[4-(chloromethyl)phenyl]carbonyl}amino)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g]diquinolin-1-ium-6-yl)benzoate
5-({[4-(chloromethyl)phenyl]carbonyl}amino)-2-(1,2,2,4,8,10,10,11-octamethyl-10,11-dihydro-2H-pyrano[3,2-g:5,6-g]diquinolin-1-ium-6-yl)benzoate
tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate
tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
4,4,4-trifluoro-N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(4-methylphenyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
4,4,4-trifluoro-N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(4-methylphenyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide
N-(2-aminophenyl)-4-[[[(2S,3R)-9-(benzenesulfonamido)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(2S,3R)-9-(benzenesulfonamido)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
4-fluoro-N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide
4-fluoro-N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide
N-(2-aminophenyl)-4-[[[(2R,3R)-9-(benzenesulfonamido)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(2R,3R)-9-(benzenesulfonamido)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
4-fluoro-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide
4-fluoro-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide
8-[1-azocanyl(oxo)methyl]-6-[2-(2-hydroxyethoxy)phenyl]-3,4-diphenylspiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1,2-dione
8-[1-azocanyl(oxo)methyl]-6-[2-(2-hydroxyethoxy)phenyl]-3,4-diphenylspiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-1,2-dione
1-amino-N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-2,5,8,11-tetraoxatetradecan-14-amide
1-amino-N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-2,5,8,11-tetraoxatetradecan-14-amide
Aconitane-7,8-diol, 4-(((2-((4-amino-1,4-dioxobutyl)amino)benzoyl)oxy)methyl)-20-ethyl-1,6,14,16-tetramethoxy-, (1alpha,6beta,14alpha,16beta)-
Aconitane-7,8-diol, 4-(((2-((4-amino-1,4-dioxobutyl)amino)benzoyl)oxy)methyl)-20-ethyl-1,6,14,16-tetramethoxy-, (1alpha,6beta,14alpha,16beta)-
Endomorphin 2 (TFA)
Endomorphin 2 (TFA)
Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1]. Endomorphin 2 TFA, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM[1].
(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
n'-{2-[({11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methoxy)carbonyl]phenyl}-2-methylbutanediimidic acid
n'-{2-[({11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methoxy)carbonyl]phenyl}-2-methylbutanediimidic acid
(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaene-6,18,32,34-tetrone
(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-3,7,9,11,17,21,27-heptamethyl-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaene-6,18,32,34-tetrone
(2e)-n-[2-(3-chloro-4-methoxyphenyl)-1-{[2-methyl-2-(methyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]-5-[(2-hydroxy-4-methylpentanoyl)oxy]-6-(3-phenyloxiran-2-yl)hept-2-enimidic acid
(2e)-n-[2-(3-chloro-4-methoxyphenyl)-1-{[2-methyl-2-(methyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]-5-[(2-hydroxy-4-methylpentanoyl)oxy]-6-(3-phenyloxiran-2-yl)hept-2-enimidic acid
1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-furoyloxy-11-(2-methyl)butyryloxy-4β-hy-droxydihydro-β-agarofuran
NA
{"Ingredient_id": "HBIN002313","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-furoyloxy-11-(2-methyl)butyryloxy-4\u03b2-hy-droxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C35H43NO13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
awadcharidine
NA
{"Ingredient_id": "HBIN017411","Ingredient_name": "awadcharidine","Alias": "NA","Ingredient_formula": "C36H51N3O10","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CCC(=O)N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2042","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
n-[2-({[(1s,2r,3r,4s,5r,6s,8r,9s,13s,16s,17r,18r)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]butanediimidic acid
n-[2-({[(1s,2r,3r,4s,5r,6s,8r,9s,13s,16s,17r,18r)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]butanediimidic acid
(2r)-n'-[2-({[(1r,2r,3r,4s,5s,6s,8r,9r,10r,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
(2r)-n'-[2-({[(1r,2r,3r,4s,5s,6s,8r,9r,10r,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,22r)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,22r)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate
4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-11-(sec-butyl)-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-11-(sec-butyl)-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(2s,5s,8s,11s,14s,15r)-11-[(2s)-butan-2-yl]-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(2s,5s,8s,11s,14s,15r)-11-[(2s)-butan-2-yl]-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(2r)-n'-[2-({[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
(2r)-n'-[2-({[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
4-{[hydroxy(2-{1-hydroxy-3-[(1-hydroxy-2-{[hydroxy(1-methylpiperidin-2-yl)methylidene]amino}-3-methylpentylidene)amino]-4-methyl-2-oxopentyl}-1,3-thiazol-4-yl)methylidene]amino}-2-methyl-5-phenylpentanoic acid
4-{[hydroxy(2-{1-hydroxy-3-[(1-hydroxy-2-{[hydroxy(1-methylpiperidin-2-yl)methylidene]amino}-3-methylpentylidene)amino]-4-methyl-2-oxopentyl}-1,3-thiazol-4-yl)methylidene]amino}-2-methyl-5-phenylpentanoic acid
(2s,4r)-4-{[hydroxy({2-[(3s)-1-hydroxy-3-{[(2s,3s)-1-hydroxy-2-({hydroxy[(2r)-1-methylpiperidin-2-yl]methylidene}amino)-3-methylpentylidene]amino}-4-methyl-2-oxopentyl]-1,3-thiazol-4-yl})methylidene]amino}-2-methyl-5-phenylpentanoic acid
(2s,4r)-4-{[hydroxy({2-[(3s)-1-hydroxy-3-{[(2s,3s)-1-hydroxy-2-({hydroxy[(2r)-1-methylpiperidin-2-yl]methylidene}amino)-3-methylpentylidene]amino}-4-methyl-2-oxopentyl]-1,3-thiazol-4-yl})methylidene]amino}-2-methyl-5-phenylpentanoic acid
(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
methyl (1r,2r,4s)-4-{[(2r,4s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
methyl (1r,2r,4s)-4-{[(2r,4s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
4,12-bis(acetyloxy)-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate
2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,25-hexaen-13-yl acetate
(1s,2r,3r,4s,5s,7r,8r,9r,10r,11s,12s,14r,15r)-2,8,12-tris(acetyloxy)-7-hydroxy-5,9,12-trimethyl-16-oxo-4-(propanoyloxy)-18-oxapentacyclo[7.7.2.0¹,¹⁰.0³,⁷.0¹¹,¹⁴]octadecan-15-yl pyridine-3-carboxylate
(1s,2r,3r,4s,5s,7r,8r,9r,10r,11s,12s,14r,15r)-2,8,12-tris(acetyloxy)-7-hydroxy-5,9,12-trimethyl-16-oxo-4-(propanoyloxy)-18-oxapentacyclo[7.7.2.0¹,¹⁰.0³,⁷.0¹¹,¹⁴]octadecan-15-yl pyridine-3-carboxylate
methyl (1r,2r,4s)-4-{[(2s,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
methyl (1r,2r,4s)-4-{[(2s,4s,5r,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-2-methyl-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(2s,5s,8s,11s,14s,15r)-11-[(2r)-butan-2-yl]-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(2s,5s,8s,11s,14s,15r)-11-[(2r)-butan-2-yl]-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,14-tetramethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(2s)-2-{[(2e)-2-{[(2s)-2-({[(3s)-2-[(2s,3s)-3-amino-2-{[(2s)-2-{[2-amino-1,3-dihydroxy-2-(hydroxymethyl)propylidene]amino}-1-hydroxypropylidene]amino}butanoyl]-4,5-dihydro-3h-pyridazin-3-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}-3-hydroxypropanoic acid
(2s)-2-{[(2e)-2-{[(2s)-2-({[(3s)-2-[(2s,3s)-3-amino-2-{[(2s)-2-{[2-amino-1,3-dihydroxy-2-(hydroxymethyl)propylidene]amino}-1-hydroxypropylidene]amino}butanoyl]-4,5-dihydro-3h-pyridazin-3-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}-3-hydroxypropanoic acid
(2r)-n'-[2-({[(1r,2r,3r,4s,5s,6s,8r,9r,10r,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
(2r)-n'-[2-({[(1r,2r,3r,4s,5s,6s,8r,9r,10r,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]-2-methylbutanediimidic acid
